Literature DB >> 29332358

A study on basic demographic and disease characteristics of cancer-diagnosed Syrian refugees treated in the border city of Turkey, Sanliurfa; a hospital-based retrospective case series study.

Yasemin Bakkal Temi1, Ali Murat Sedef, Serkan Gokcay, Hatice Coskun, Sedenay Oskeroglu Kaplan, Ozlem Ozkul, Huseyin Mertsoylu, Fatih Kose.   

Abstract

PURPOSE: Turkey hosts around 3 million Syrian refugees which is more than any other country in the world. Along with some other adaptation issues like cultural, language, and economic difficulties, significant problems in managing medical problems, chronic diseases like cancer in particular, have to be fixed. However, there are few studies which explore main patient and clinicopathological characteristics in Syrian refugees with cancer. The purpose of this study was to highlight the aforementioned characteristics along with management issues after cancer diagnosis of these patients.
METHODS: This study was designed as a hospital-based retrospective observational case-series study of 134 Syrian refugees cancer patients between 2015 and 2017.
RESULTS: The patient median age was 47.5 years (range 18- 80). Out of the 134, 102 (76.1%) were female. The most common cancer types were breast (n=57, 42.5%) and gynecological cancers (n=14, 10.4%). The majority of patients were diagnosed at advanced stage (n=60, 44.8%). There were 91 (67.9%) and 43 (32.1%) patients admitted to our center from refugee camps and staying in a house, respectively. The median follow-up was 14 months (range 1-111) and 11 (8.2%) patients died. One and two-year survival rate of the whole group were 93% and 86%, respectively. There were 12 (9%) patients with grade 3-4 hematological and non-hematological toxicities. Neutropenia was the most common grade 3-4 toxicity (n=8, 6%). The patients staying in refugee camp (n-91) or in a house (n=43) finished all planned cycles of chemotherapy with a rate of 71% (n=65) and 79% (n=34), respectively. Statistical analysis failed to show significant relationship between the staying site (either camp or house), chemotherapy compliance rate, grade 3-4 toxicities with p=0.347 and p=0.09, respectively.
CONCLUSION: Our results revealed that breast cancer and gynecological cancers were the most common cancer types which are good candidates for cancer screening. Unfortunately, the majority of patients had cancer diagnosed at advanced stage. However, after diagnosis they could reach all health facilities including surgical operation, radiotherapy, and systemic chemotherapy similar to Turkish cancer patients. Therefore, our results suggested that major problem for the Syrian refugees adapting them into national screening program which may resulted that cancer diagnosis at earlier stage with high cure rate.

Entities:  

Mesh:

Year:  2017        PMID: 29332358

Source DB:  PubMed          Journal:  J BUON        ISSN: 1107-0625            Impact factor:   2.533


  7 in total

1.  Access to Radiation Therapy by Syrian Refugees Displaced to Turkey.

Authors:  Nergiz Dagoglu; Sule Karaman; Banu Atalar; Robert C Miller; Ethem N Oral
Journal:  Adv Radiat Oncol       Date:  2022-07-15

2.  Breast cancer awareness among Afghan refugee women in Turkey.

Authors:  Mehmet Celal Kizilkaya; Sarah Sabrine Kilic; Mehmet Abdussamet Bozkurt; Osman Sibic; Nisha Ohri; Meredith Faggen; Laura Warren; Julia Wong; Rinaa Punglia; Jennifer Bellon; Bruce Haffty; Mutlay Sayan
Journal:  EClinicalMedicine       Date:  2022-06-03

3.  Delivering non-communicable disease interventions to women and children in conflict settings: a systematic review.

Authors:  Shailja Shah; Mariella Munyuzangabo; Michelle F Gaffey; Mahdis Kamali; Reena P Jain; Daina Als; Sarah Meteke; Amruta Radhakrishnan; Fahad J Siddiqui; Anushka Ataullahjan; Zulfiqar A Bhutta
Journal:  BMJ Glob Health       Date:  2020-04

4.  Utilization of radiation therapy and predictors of noncompliance among Syrian refugees in Turkey.

Authors:  Mutlay Sayan; Mehmet Fuat Eren; Sarah Sabrine Kilic; Ayse Kotek; Sedenay Oskeroglu Kaplan; Ozge Duran; Funda Cukurcayır; Ibrahim Babalıoglu; Ozlem Derinalp Or; Gul Aysen Ozturk; Celalettin Eroglu; Fatma Teke; Neslihan Kurtul; Tugce Kutuk; Beyhan Ceylaner Bicakci; Sukran Senyurek; Meryem Aktan; Swati Mamidanna; Nisha Ohri; Bruce Haffty; Banu Atalar
Journal:  BMC Cancer       Date:  2022-05-12       Impact factor: 4.638

Review 5.  Barriers and Facilitators Influencing Arab Muslim Immigrant and Refugee Women's Breast Cancer Screening: A Narrative Review.

Authors:  Louise Racine; Isil Isik Andsoy
Journal:  J Transcult Nurs       Date:  2022-04-26       Impact factor: 1.869

6.  Late presentation and suboptimal treatment of breast cancer among Syrian refugees: a retrospective study.

Authors:  Hikmat Abdel-Razeq; Faris Tamimi; Nayef Abdel-Razeq; Maryam El-Atrash; Baha' Sharaf; Rawan Mustafa; Razan Mansour; Rayan Bater
Journal:  J Int Med Res       Date:  2021-05       Impact factor: 1.671

7.  Cancer among syrian refugees living in Konya Province, Turkey.

Authors:  Tezer Kutluk; Mehmet Koç; İrem Öner; İbrahim Babalıoğlu; Meral Kirazlı; Sinem Aydın; Fahad Ahmed; Yavuz Köksal; Hüseyin Tokgöz; Mustafa Duran; Richard Sullivan
Journal:  Confl Health       Date:  2022-01-31       Impact factor: 2.723

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.